India, July 17 -- Miltenyi Biotec, a global leader in cell and gene therapy (CGT) technologies, has signed a Letter of Intent (LOI) with the Translational Health Science and Technology Institute (THSTI), Faridabad, to establish India's first hands-on training programme in clinical cell manufacturing.
This groundbreaking collaboration, initiated by Miltenyi Biotec and certified under the aegis of the Biotechnology Industry Research Assistance Council (BIRAC), aims to bridge India's talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
The training programme will be hosted at THSTI's GMP facility, with Miltenyi Biotec deploying its cutting...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.